Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Analysis of Cardiotoxic Medication Use Due to Sodium Arsenite Chloride Injection

NCT06060132 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT06060132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06060132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Analysis of Cardiotoxic Medication Use Due to Sodium Arsenite Chloride Injection
Lead sponsor
Qianfoshan Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 29, 2023
Completion date
December 31, 2023
Enrollment
400 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adverse reaction, cardiotoxicity, evaluation study